EmA Approves Combined COVID-19 and Flu mRNA Vaccine

01 Apr 20264 min read0 viewsJournal Feed

GIST

The EMA approved Moderna's mRNA COVID-19 and flu vaccine, but US political battles and funding cuts threaten the future of mRNA vaccine innovation. Talha Burki reports.

Clinical Editorial

Summary

The Lancet Infectious Diseases published a clinical update in Infectious Disease on 01 Apr 2026.

The item focuses on EMA approves combined COVID-19 and flu mRNA vaccine.

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

10.1016/S1473-3099(26)00130-1

Open Original Source More Feed Items

Related by Condition/Drug

Nat ImmunolRelated by Conditioncovid-19

A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines

Infectious Disease • 22 May 2026

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra

Infectious Disease • 22 May 2026

De novo COVID-19-associated insulin resistance drives dysregulated neutrophil extracellular trap formation (NETosis) four months after infection

Infectious Disease • 04 May 2026

CDC EIDRelated by Conditioncovid-19

Retrospective Phylogenetic Analysis of Mayaro Virus in French Guiana, 1996–2024

Infectious Disease • 27 Apr 2026

WHORelated by Conditioncovid-19

Types of Data Requested to Inform May 2026 COVID-19 Vaccine Antigen Composition Deliberations

Infectious Disease • 30 Mar 2026

WHORelated by Conditioncovid-19

Types Of Data Requested To Inform May 2026 Covid-19 Vaccine Antigen Composition Deliberations

Infectious Disease • 30 Mar 2026

Feed Metadata

Source

The Lancet Infectious Diseases